Journal
JOURNAL OF DIABETES
Volume 4, Issue 3, Pages 257-261Publisher
WILEY
DOI: 10.1111/j.1753-0407.2012.00205.x
Keywords
angiotensin-converting enzyme (ACE) I; D polymorphism; diabetic peripheral neuropathy; type 2 diabetes mellitus
Categories
Ask authors/readers for more resources
Background: Diabetic peripheral neuropathy (DPN) is one of the complications of type 2 diabetes mellitus (T2DM) that decreases the quality of life of T2DM patients. Very few studies have found an association between the development and progression of DPN in T2DM and angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphisms. Methods: Using gene-specific primers in a polymerase chain reaction, the presence of ACE I/D polymorphisms was screened for in 276 T2DM patients with DPN, 496 T2DM patients without DPN, and 331 control (non-diabetic) subjects. Results: The distribution of the I/D genotypes was in HardyWeinberg equilibrium. The II genotype was significantly more prevalent in T2DM patients without DPN than the DD genotype (P < 0.05); however, there was no significant difference in the prevalence of the II and DD genotypes in T2DM patients with DPN (P = 0.78). Conclusion: The II genotype of the ACE gene has a protective effect against the development of DPN in T2DM patients. This suggests a role for the reninangiotensin system in modulating neuropathy in T2DM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available